Multisite rTMS for Mood, Cognitive Impairment and Other Symptoms of Depression
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Unipolar Depression, Bipolar Disorder
In brief
Depressed mood is the main symptom of depression, but other symptoms like cognitive impairment, anhedonia or sleep disorders may also contribute to patients suffering and are difficult to treat. rTMS is a relatively novel treatment option, whose therapeutic potential is still investigated and optimized. The aim of this study is to assess the effect of rTMS applied over two stimulation sites on cognitive impairment, anhedonia and sleep disorders in depression.
Key facts
- Study ID
- NCT06363981
- Run by
- Jakub Antczak
- People needed
- 90
- Starts
- 2024-05-20
- Expected to finish
- 2027-04-01
- Last updated by the study team
- 2024-10-15
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- severe or moderate depressive episode (according to international classification of diseases (ICD)-10) without psychotic symptoms at the time of inclusion
- Hamilton Depression Rating Scale between between 20 and 35 points at inclusion
- The score in the Athens Insomnia Scale eight or more
- The score of three or more points in items 4 and 21 of the Beck Depressions Inventory 2
- Complaining about problems with memory and concentration timely related with the onset of depression
You may not qualify if…
- Contraindications to transcranial magnetic stimulation, including ferromagnetic elements in head, pregnancy and epilepsy
- Psychotic symptoms at the time of inclusion
- Suicidal ideations and/or attempts within three months prior to inclusion
Where it is running
- The Education of Research and Development Center, Babinski Clinical Hospital — Krakow, Poland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.